$NBIO News November 01, 2022 Nascent Biotech Rece
Post# of 40199
![](/assets/46931549/no_avatar_available_thumb.jpg)
Nascent Biotech Receives Notice of the Issuance of US Patent No.11,494,394
"This issuance strengthens our growing IP portfolio in our brain cancer treatment using Pritumumab, a unique natural antibody that crosses the blood brain barrier," said Sean Carrick, CEO of Nascent.
https://finance.yahoo.com/news/nascent-biotec...00713.html
$ACRZF $CLABD $CTTQF $FTROF $IOIOF $LOWLF $OPTHF $WKULF $SDPNF $TSLLF
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)